Endpoints News· @endpts · X·· 20 天前AI 评分38
AI 导读
分析师在关键三期数据读出前追问渤健狼疮药物litifilimab,这些数据对CEO Chris Viehbacher的转型至关重要。https://endpoints.news/analysts-press-biogen-on-lupus-drug-litifilimab-ahead-of-pivotal-readouts/?utm_source=Twitter&utm_medium=organic_social&utm_campaign=editorial
正文
Analysts pressed Biogen on lupus drug litifilimab ahead of Phase 3 readouts pivotal to CEO Chris Viehbacher’s turnaround. https://endpoints.news/analysts-press-biogen-on-lupus-drug-litifilimab-ahead-of-pivotal-readouts/?utm_source=Twitter&utm_medium=organic_social&utm_campaign=editorial
来源:Endpoints News · x.com